Great Valley Advisor Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-575	Closed	-$365K	–	933
2025 Q1	$365K	Buy	575 +98	+21%	+$67.4K	0.01%	667
2024 Q4	$340K	Buy	477 +35	+8%	+$29.4K	0.01%	668
2024 Q3	$465K	Buy	442 +21	+5%	+$23.4K	0.01%	580
2024 Q2	$443K	Sell	421 -233	-36%	-$226K	0.01%	554
2024 Q1	$629K	Buy	654 +2	+0.3%	+$1.9K	0.02%	446
2023 Q4	$573K	Sell	652 -502	-44%	-$413K	0.02%	430
2023 Q3	$950K	Buy	1,154 +218	+23%	+$171K	0.04%	322
2023 Q2	$673K	Buy	936 +172	+23%	+$133K	0.03%	382
2023 Q1	$628K	Buy	+764	New	+$576K	0.03%	394
2021 Q4	–	Sell	-543	Closed	-$329K	–	616
2021 Q3	$329K	Buy	+543	New	+$337K	0.02%	444
2020 Q4	–	Sell	-417	Closed	-$233K	–	481
2020 Q3	$233K	Buy	417 +54	+15%	+$32.7K	0.03%	378
2020 Q2	$227K	Buy	+363	New	+$206K	0.04%	365